Upload
hailey
View
30
Download
0
Tags:
Embed Size (px)
DESCRIPTION
Comparison of US and European Guidelines. Oral Antiplatelet Therapy in Primary PCI/STEMI. GP IIb/IIIa Inhibitors in Primary PCI/STEMI. EUROMAX Bleeding Outcomes at 30 d. HORIZONS-AMI Bleeding Outcomes at 30 d in a Primary PCI Population. - PowerPoint PPT Presentation
Citation preview
Comparison of US and European Guidelines
Oral Antiplatelet Therapy in Primary PCI/STEMI
GP IIb/IIIa Inhibitors in Primary PCI/STEMI
EUROMAXBleeding Outcomes at 30 d
HORIZONS-AMIBleeding Outcomes at 30 d in a Primary PCI
Population
CHAMPION PHOENIX Primary Efficacy Outcomes at 48 h, MITT
Anticoagulation in Primary PCI/STEMI
FUTURA/OASIS 8
Oral Antiplatelet Therapy in Non-ST Elevation ACS
CHARISMABleeding End Points by Baseline Daily Aspirin
Dose
CURRENTEfficacy and Bleeding by Aspirin Dose
EARLY-ACSBleeding Outcomes at 30 days
GP IIb/IIIa Inhibitors in Primary PCI/Non-ST-segment Elevation ACS
PLATO SubanalysisEfficacy and Safety End Points
Anticoagulation in Non-ST-segment Elevation ACS
OASIS 5 -- Cumulative Risk of Death, MI, or Refractory Ischemia
The Future for ACS Management?
Abbreviations
Abbreviations (cont)
References
References (cont)
References (cont)
References (cont)
References (cont)